SecBot SecBot
PRESS-RELEASE ·Filed Apr 23, 2026

APYX

Apyx Medical Corporation
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

Traders should prepare for potential volatility following the May 7 earnings release and call; monitor for revenue trends, gross margins, and any update to full-year guidance, particularly around AYON adoption and international expansion.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
APYX ▲ +7.11% at T+60d
NEUTRAL call +7.11% · α vs SPY +2.09% · entry $3.80 → $4.07
Entry = T+0 close
Apr 23, 2026
via day close
T+1d
-2.11%
call -2.11% · α -2.89%
$3.72
settled 6mo ago
T+5d
-8.95%
call -8.95% · α -10.43%
$3.46
settled 6mo ago
T+20d
-0.26%
call -0.26% · α -4.90%
$3.79
settled 5mo ago
T+60d
+7.11%
call +7.11% · α +2.09%
$4.07
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Apyx Medical announced it will release its Q1 fiscal 2026 financial results on May 7, 2026, followed by a conference call to discuss performance. This is a routine earnings announcement with no financial data disclosed.

Key Facts

  • Apyx Medical will release Q1 FY2026 financial results on May 7, 2026, before market open.
  • Management will host a conference call at 8:00 a.m. ET on May 7 to discuss results and answer questions.
  • No financial results or guidance updates were provided in this press release.

Financial Impact

None at this time — financial results not yet disclosed

Risk Factors

  • Earnings could miss expectations given Apyx's history of volatility and competitive pressures in the aesthetics market.
  • Lack of disclosed metrics ahead of the call increases uncertainty and potential for post-earnings volatility.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3279823
8 reports for APYX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for APYX — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
Press Release
NEUTRAL ★ 1/10
$2.41awaiting T+20—$2.37 (−1.66%)
Aug 7, 2026
11w ago
8-K
NEUTRAL ★ 3/10
$3.46 $3.05▼ −11.85%▼ −10.94%$2.37 (−31.50%)
May 21, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$4.13 $3.95▼ −4.36%▼ −2.94%$2.37 (−42.62%)
May 21, 2026
22w ago
Press Release
NEUTRAL ★ 3/10
$4.25 $4.04▼ −4.94%▼ −5.27%$2.37 (−44.24%)
May 14, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$4.36 $4.69▲ +7.57%▲ +8.43%$2.37 (−45.64%)
May 11, 2026
24w ago
8-K
BULLISH ★ 6/10
$3.92 $4.86▲ +23.98%▲ +24.28%$2.37 (−39.54%)
Apr 23, 2026
26w ago
Press Release
NEUTRAL ★ 3/10
$3.80 $3.79▼ −0.26%▼ −4.90%$2.37 (−37.63%)
Mar 10, 2026
32w ago
Press Release
BULLISH ★ 8/10
$3.45 $3.81▲ +10.43%▲ +10.59%$2.37 (−31.30%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (12h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026